As such, we argue explicitly mandating or even implying the necessity of experiential training for psychedelic researchers and clinicians can perpetuate ableism in medicine by excluding those who cannot safely use psychedelics because of their personal medical histories. As PAP research and practice ...
Scheduling these drugs has presented an additional barrier in their clinical exploration. The challenges and limitations in researching them — while necessary for patient safety and ethical practices — can also make it difficult to assess the psychopharmacology and effects of psychedelics fully....
MindBio is working towards the commercialization of microdosing treatments with a package of proprietary solutions for safe and effective at home use of psychedelics. MindBio remains the only organization in the world approved for...
The passage makes Colorado, which was one of the first states to legalize recreational marijuana, the second state to allow the use of psychedelics behind Oregon. Proposition 122, or the “Natural Medicine Health Act of 2022,” passed with 53 percent of Colorado voters supporting the initiat...
the main conclusion of an online survey of 2,800 people conducted by a research team led by Michel Dorval, professor at Université Laval's Faculty of Pharmacy and researcher at the CHU de Québec-Université Laval Research Center. The results have beenpublishedin the journalPalliative Medicine. ...
“I’m fighting for psychedelics to become medicine you can buy over the counter,” he says. But just how helpful are these substances, and what risks can they pose to your health? Where Is It Found? The Sonoran Desert Toad spends seven months of the year living underground, but when ...
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis Article Open access 26 June 2024 Dose response effects of theacrine on cognitive performance and subsequent sleep Article Open access 19 November 2024 EEG reve...
Ketamine, an essential medicine according to WHO, has health and addiction risks in recreational use. Increasing numbers ofketamineusers are asking if they may be addicted to ketamine. The answer often is yes. We don’t yet know how widespread ketamine use disorder (KUD) is. Still, the inter...
Those substances included in the first are considered to have a high potential for “abuse”, but without being of medical use, at least not according to the general opinion in medicine. Schedule II substances are perceived as similarly dangerous, because of their potential to lead to severe ...
This review strengthens support for translational studies testing psychedelics as potential innovative targets for OUD. It also suggests clinical studies need to include a broader range of agents beyondibogaderivatives but can also explore several ongoing questions in the field, such as the mechanism of...